Parameter | ≤ 3 cm (n = 422) | 3~9 cm (n = 1072) | > 9 cm (n = 266) | p value | ||
---|---|---|---|---|---|---|
≤ 3 vs. 3~9 | 3~9 vs. > 9 | ≤ 3 vs. > 9 | ||||
Age, years | Â | Â | Â | Â | Â | Â |
 ≤ 50 | 212 (50.2%) | 534 (49.8%) | 139 (52.3%) | 0.928 | 0.519 | 0.662 |
 > 50 | 210 (49.8%) | 538 (50.2%) | 127 (47.7%) |  |  |  |
Sex | Â | Â | Â | Â | Â | Â |
 Male | 346 (82.0%) | 928 (86.6%) | 223 (83.8%) | 0.0303 | 0.293 | 0.604 |
 Female | 76 (18.0%) | 144 (13.4%) | 43 (16.2%) |  |  |  |
AFP, ng/mL | Â | Â | Â | Â | Â | Â |
 ≤ 20 | 183 (43.4%) | 471 (43.9%) | 72 (27.1%) | < 0.001 | < 0.001 | < 0.001 |
 20–400 | 140 (33.2%) | 249 (23.2%) | 62 (23.3%) |  |  |  |
 ≥ 400 | 99 (23.5%) | 352 (32.8%) | 132 (49.6%) |  |  |  |
HBV DNA, IU/ml | Â | Â | Â | Â | Â | |
 ≤ 1000 | 213 (50.5%) | 488 (45.5%) | 100 (37.6%) | 0.0951 | 0.0236 | 0.00126 |
 > 1000 | 209 (49.5%) | 584 (54.5%) | 166 (62.4%) |  |  |  |
White blood cells, 109/L | Â | Â | Â | Â | Â | |
 < 4 | 131 (31.0%) | 236 (22.0%) | 41 (15.4%) | < 0.001 | 0.0218 | < 0.001 |
 ≥ 4 | 291 (69.0%) | 836 (78.0%) | 225 (84.6%) |  |  |  |
Platelet count, 109/L | Â | Â | Â | Â | Â | |
 < 100 | 115 (27.3%) | 193 (18.0%) | 15 (5.6%) | < 0.001 | < 0.001 | < 0.001 |
 ≥ 100 | 307 (72.7%) | 879 (82.0%) | 251 (94.4%) |  |  |  |
Albumin, g/L | Â | Â | Â | Â | Â | |
 < 35 | 10 (2.4%) | 29 (2.7%) | 14 (5.3%) | 0.852 | 0.0545 | 0.0717 |
 ≥ 35 | 412 (97.6%) | 1043 (97.3%) | 252 (94.7%) |  |  |  |
Total bilirubin, μmol/L |  |  |  |  |  | |
 ≤ 17.1 | 314 (74.4%) | 822 (76.7%) | 205 (77.1%) | 0.391 | 0.958 | 0.485 |
 > 17.1 | 108 (25.6%) | 250 (23.3%) | 61 (22.9%) |  |  |  |
γ-Glutamyl transferase, IU/L |  |  |  |  |  | |
 ≤ 64 | 300 (71.1%) | 663 (61.8%) | 62 (23.3%) | < 0.001 | < 0.001 | < 0.001 |
 > 64 | 122 (28.9%) | 409 (38.2%) | 204 (76.7%) |  |  |  |
Alkaline phosphatase, IU/L | Â | Â | Â | Â | Â | |
 ≤ 129 | 410 (97.2%) | 998 (93.1%) | 181 (68.0%) | 0.00362 | < 0.001 | < 0.001 |
 > 129 | 12 (2.8%) | 74 (6.9%) | 85 (32.0%) |  |  |  |
ALBI grade | Â | Â | Â | Â | Â | Â |
 ≤ − 2.63 | 321 (76.1%) | 795 (74.2%) | 154 (57.9%) | 0.486 | < 0.001 | < 0.001 |
 > 2.63 | 101 (23.9%) | 277 (25.8%) | 112 (42.1%) |  |  |  |
Blood loss, mL | Â | Â | Â | Â | Â | |
 < 800 | 417 (98.8%) | 1024 (95.5%) | 209 (78.6%) | 0.00326 | < 0.001 | < 0.001 |
 ≥ 800 | 5 (1.2%) | 48 (4.5%) | 57 (21.4%) |  |  |  |
Differentiation degree | Â | Â | Â | Â | Â | |
 I/II | 105 (24.9%) | 174 (16.2%) | 16 (6.0%) | <0.001 | <0.001 | <0.001 |
 III/IV | 317 (75.1%) | 898 (83.8%) | 250 (94.0%) |  |  |  |
Microvascular invasion | Â | Â | Â | Â | Â | |
 Negative | 349 (82.7%) | 830 (77.4%) | 175 (65.8%) | 0.0292 | < 0.001 | < 0.001 |
 Positive | 73 (17.3%) | 242 (22.6%) | 91 (34.2%) |  |  |  |
Tumor capsule | Â | Â | Â | Â | Â | |
 Incomplete/absent | 292 (69.2%) | 735 (68.6%) | 205 (77.1%) | 0.861 | 0.00827 | 0.0309 |
 Complete | 130 (30.8%) | 337 (31.4%) | 61 (22.9%) |  |  |  |
Cirrhosis | Â | Â | Â | Â | Â | Â |
 Absent | 157 (37.2%) | 588 (54.9%) | 182 (68.4%) | < 0.001 | < 0.001 | < 0.001 |
 Present | 265 (62.8%) | 484 (45.1%) | 84 (31.6%) |  |  |  |